tradingkey.logo

Basel Medical Group Ltd

BMGL
0.720USD
-0.020-2.70%
收盤 12/19, 16:00美東報價延遲15分鐘
13.53M總市值
虧損本益比TTM

Basel Medical Group Ltd

0.720
-0.020-2.70%

關於 Basel Medical Group Ltd 公司

Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.

Basel Medical Group Ltd簡介

公司代碼BMGL
公司名稱Basel Medical Group Ltd
上市日期Feb 25, 2025
CEOChhoa (Yen Feng)
員工數量77
證券類型Ordinary Share
年結日Feb 25
公司地址600 North Bridge Road, #12-02/03
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Singapore
郵編188778
電話6562919188
網址https://www.baselmedical.com
公司代碼BMGL
上市日期Feb 25, 2025
CEOChhoa (Yen Feng)

Basel Medical Group Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月24日 週一
更新時間: 11月24日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
其他
44.29%
持股股東
持股股東
佔比
Rainforest Capital VCC
54.32%
Citadel Advisors LLC
0.49%
Morgan Stanley & Co. LLC
0.40%
Marex Group plc
0.31%
Virtu Americas LLC
0.18%
其他
44.29%
股東類型
持股股東
佔比
Corporation
54.32%
Research Firm
0.58%
Hedge Fund
0.49%
Investment Advisor
0.47%
Investment Advisor/Hedge Fund
0.04%
其他
44.10%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
14
296.50K
0.70%
--
2025Q3
14
296.50K
0.70%
+165.18K
2025Q2
6
124.34K
0.00%
+124.34K
2025Q1
5
12.74M
67.81%
+12.74M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Rainforest Capital VCC
10.17M
54.16%
+10.17M
--
Feb 25, 2025
Marex Group plc
13.92K
0.07%
+13.92K
--
Jun 30, 2025
Virtu Americas LLC
16.18K
0.09%
+16.18K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
6.97K
0.04%
--
--
Aug 31, 2025
UBS Financial Services, Inc.
5.64K
0.03%
+5.64K
--
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Basel Medical Group Ltd的前五大股東是誰?

Basel Medical Group Ltd的前五大股東如下:
Rainforest Capital VCC
持有股份:10.17M
佔總股份比例:54.16%。
Marex Group plc
持有股份:13.92K
佔總股份比例:0.07%。
Virtu Americas LLC
持有股份:16.18K
佔總股份比例:0.09%。
Geode Capital Management, L.L.C.
持有股份:6.97K
佔總股份比例:0.04%。
UBS Financial Services, Inc.
持有股份:5.64K
佔總股份比例:0.03%。

Basel Medical Group Ltd的前三大股東類型是什麼?

Basel Medical Group Ltd 的前三大股東類型分別是:
Rainforest Capital VCC
Citadel Advisors LLC
Morgan Stanley & Co. LLC

有多少機構持有Basel Medical Group Ltd(BMGL)的股份?

截至2025Q4,共有14家機構持有Basel Medical Group Ltd的股份,合計持有的股份價值約為296.50K,占公司總股份的0.70% 。與2025Q3相比,機構持股有所增加,增幅為--。

哪個業務部門對Basel Medical Group Ltd的收入貢獻最大?

在--,--業務部門對Basel Medical Group Ltd的收入貢獻最大,創收--,占總收入的--% 。
KeyAI